Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease; Dementia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01009476
What this trial is testing

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

Who this might be right for
DementiaAlzheimer DiseaseDementia, Vascular
Janssen-Cilag G.m.b.H 1,134
Not applicableLooking for participantsNCT05877391
What this trial is testing

Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice

Who this might be right for
Sexual and Gender MinoritiesHospiceAlzheimer's Disease and Related Dementias
University of Colorado, Denver 80
Not applicableStudy completedNCT02021682
What this trial is testing

CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 58
Early research (Phase 1)Study completedNCT01600859
What this trial is testing

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

Who this might be right for
Alzheimer's Disease
Eisai Inc. 65
Early research (Phase 1)Study completedNCT03720548
What this trial is testing

LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 36
Not applicableStudy completedNCT04842955
What this trial is testing

Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD)

Who this might be right for
Alzheimer Disease
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 60
Not applicableUnknownNCT02349191
What this trial is testing

Omental Transposition Surgery for Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bariatric Medicine Institute, Salt Lake City, UT 25
Not applicableStudy completedNCT05642052
What this trial is testing

Feasibility Study of a Community Pilot Project for the Prevention of Alzheimer's Disease: the KetoHome Study.

Who this might be right for
Alzheimer DiseaseGlucose Metabolism
Université de Sherbrooke 25
Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Not applicableNot Yet RecruitingNCT07122856
What this trial is testing

Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients

Who this might be right for
Alzheimer DiseaseMini-Mental State ExaminationCognitive Dysfunction+2 more
Centre Hospitalier de Gonesse 100
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Not applicableStudy completedNCT04628702
What this trial is testing

Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia

Who this might be right for
Alzheimer Disease
Medical University of Graz 24
Not applicableUnknownNCT01570322
What this trial is testing

Determinants of Quality of Life Related to Health in Alzheimer Disease

Who this might be right for
Alzheimer Disease
CHU de Reims 400
Testing effectiveness (Phase 2)Ended earlyNCT00069849
What this trial is testing

The Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Abbott 64
Post-approval studies (Phase 4)Study completedNCT01054976
What this trial is testing

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Korea, Ltd., Korea 99
Not applicableStudy completedNCT00597376
What this trial is testing

Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints

Who this might be right for
Subjective Memory Loss in Older Persons
Rush University Medical Center 104
Post-approval studies (Phase 4)Ended earlyNCT01832350
What this trial is testing

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePseudobulbar Affect (PBA)
St. Joseph's Hospital and Medical Center, Phoenix 34
Large-scale testing (Phase 3)Active Not RecruitingNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 1,060
Early research (Phase 1)Study completedNCT00906191
What this trial is testing

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 6
Not applicableStudy completedNCT02521818
What this trial is testing

Dietary Treatments for Cognitive Impairment in Older Adults

Who this might be right for
Mild Cognitive ImpairmentProbable Alzheimer's Disease
Johns Hopkins University 38
Next Page